nodes	percent_of_prediction	percent_of_DWPC	metapath
Silodosin—ABCB1—peripheral nervous system neoplasm	0.451	1	CbGaD
Silodosin—UGT2B7—Epirubicin—peripheral nervous system neoplasm	0.148	0.329	CbGbCtD
Silodosin—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0504	0.112	CbGbCtD
Silodosin—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0504	0.112	CbGbCtD
Silodosin—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.035	0.0778	CbGbCtD
Silodosin—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0302	0.0672	CbGbCtD
Silodosin—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0281	0.0625	CbGbCtD
Silodosin—ABCB1—Vincristine—peripheral nervous system neoplasm	0.0215	0.0479	CbGbCtD
Silodosin—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.0201	0.0447	CbGbCtD
Silodosin—ABCB1—Etoposide—peripheral nervous system neoplasm	0.0197	0.0439	CbGbCtD
Silodosin—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.0135	0.0299	CbGbCtD
Silodosin—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.0129	0.0287	CbGbCtD
Silodosin—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.0118	0.0263	CbGbCtD
Silodosin—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00806	0.0179	CbGbCtD
Silodosin—Nasopharyngitis—Alitretinoin—peripheral nervous system neoplasm	0.000711	0.00725	CcSEcCtD
Silodosin—Angiopathy—Topotecan—peripheral nervous system neoplasm	0.000664	0.00676	CcSEcCtD
Silodosin—Immune system disorder—Topotecan—peripheral nervous system neoplasm	0.000661	0.00673	CcSEcCtD
Silodosin—Mediastinal disorder—Topotecan—peripheral nervous system neoplasm	0.000659	0.00672	CcSEcCtD
Silodosin—Angiopathy—Tretinoin—peripheral nervous system neoplasm	0.000658	0.00671	CcSEcCtD
Silodosin—Angiopathy—Isotretinoin—peripheral nervous system neoplasm	0.000658	0.00671	CcSEcCtD
Silodosin—Immune system disorder—Melphalan—peripheral nervous system neoplasm	0.000647	0.00659	CcSEcCtD
Silodosin—Mediastinal disorder—Melphalan—peripheral nervous system neoplasm	0.000646	0.00658	CcSEcCtD
Silodosin—Mental disorder—Tretinoin—peripheral nervous system neoplasm	0.000636	0.00648	CcSEcCtD
Silodosin—Mental disorder—Isotretinoin—peripheral nervous system neoplasm	0.000636	0.00648	CcSEcCtD
Silodosin—Orthostatic hypotension—Cisplatin—peripheral nervous system neoplasm	0.000619	0.00631	CcSEcCtD
Silodosin—Breast disorder—Cisplatin—peripheral nervous system neoplasm	0.000612	0.00624	CcSEcCtD
Silodosin—Erectile dysfunction—Vincristine—peripheral nervous system neoplasm	0.00061	0.00622	CcSEcCtD
Silodosin—Nasopharyngitis—Cisplatin—peripheral nervous system neoplasm	0.000606	0.00617	CcSEcCtD
Silodosin—Sinusitis—Alitretinoin—peripheral nervous system neoplasm	0.000575	0.00586	CcSEcCtD
Silodosin—Syncope—Tretinoin—peripheral nervous system neoplasm	0.000567	0.00577	CcSEcCtD
Silodosin—Syncope—Isotretinoin—peripheral nervous system neoplasm	0.000567	0.00577	CcSEcCtD
Silodosin—Palpitations—Tretinoin—peripheral nervous system neoplasm	0.000558	0.00569	CcSEcCtD
Silodosin—Palpitations—Isotretinoin—peripheral nervous system neoplasm	0.000558	0.00569	CcSEcCtD
Silodosin—Loss of consciousness—Tretinoin—peripheral nervous system neoplasm	0.000555	0.00566	CcSEcCtD
Silodosin—Loss of consciousness—Isotretinoin—peripheral nervous system neoplasm	0.000555	0.00566	CcSEcCtD
Silodosin—Unspecified disorder of skin and subcutaneous tissue—Topotecan—peripheral nervous system neoplasm	0.000538	0.00549	CcSEcCtD
Silodosin—Unspecified disorder of skin and subcutaneous tissue—Tretinoin—peripheral nervous system neoplasm	0.000534	0.00544	CcSEcCtD
Silodosin—Unspecified disorder of skin and subcutaneous tissue—Isotretinoin—peripheral nervous system neoplasm	0.000534	0.00544	CcSEcCtD
Silodosin—Unspecified disorder of skin and subcutaneous tissue—Melphalan—peripheral nervous system neoplasm	0.000527	0.00537	CcSEcCtD
Silodosin—Dry mouth—Tretinoin—peripheral nervous system neoplasm	0.000526	0.00536	CcSEcCtD
Silodosin—Dry mouth—Isotretinoin—peripheral nervous system neoplasm	0.000526	0.00536	CcSEcCtD
Silodosin—Nervous system disorder—Topotecan—peripheral nervous system neoplasm	0.00051	0.00519	CcSEcCtD
Silodosin—Shock—Isotretinoin—peripheral nervous system neoplasm	0.000507	0.00517	CcSEcCtD
Silodosin—Shock—Tretinoin—peripheral nervous system neoplasm	0.000507	0.00517	CcSEcCtD
Silodosin—Nervous system disorder—Tretinoin—peripheral nervous system neoplasm	0.000506	0.00515	CcSEcCtD
Silodosin—Nervous system disorder—Isotretinoin—peripheral nervous system neoplasm	0.000506	0.00515	CcSEcCtD
Silodosin—Skin disorder—Topotecan—peripheral nervous system neoplasm	0.000505	0.00515	CcSEcCtD
Silodosin—Tachycardia—Tretinoin—peripheral nervous system neoplasm	0.000503	0.00513	CcSEcCtD
Silodosin—Tachycardia—Isotretinoin—peripheral nervous system neoplasm	0.000503	0.00513	CcSEcCtD
Silodosin—Skin disorder—Tretinoin—peripheral nervous system neoplasm	0.000501	0.0051	CcSEcCtD
Silodosin—Skin disorder—Isotretinoin—peripheral nervous system neoplasm	0.000501	0.0051	CcSEcCtD
Silodosin—Angiopathy—Alitretinoin—peripheral nervous system neoplasm	0.000499	0.00509	CcSEcCtD
Silodosin—Tachycardia—Melphalan—peripheral nervous system neoplasm	0.000497	0.00506	CcSEcCtD
Silodosin—Skin disorder—Melphalan—peripheral nervous system neoplasm	0.000494	0.00504	CcSEcCtD
Silodosin—Hepatobiliary disease—Cisplatin—peripheral nervous system neoplasm	0.000494	0.00503	CcSEcCtD
Silodosin—Cardiac disorder—Vincristine—peripheral nervous system neoplasm	0.000492	0.00501	CcSEcCtD
Silodosin—Mental disorder—Alitretinoin—peripheral nervous system neoplasm	0.000482	0.00491	CcSEcCtD
Silodosin—Hypotension—Tretinoin—peripheral nervous system neoplasm	0.000482	0.00491	CcSEcCtD
Silodosin—Hypotension—Isotretinoin—peripheral nervous system neoplasm	0.000482	0.00491	CcSEcCtD
Silodosin—Angiopathy—Vincristine—peripheral nervous system neoplasm	0.000481	0.0049	CcSEcCtD
Silodosin—Mediastinal disorder—Vincristine—peripheral nervous system neoplasm	0.000478	0.00487	CcSEcCtD
Silodosin—Hypotension—Melphalan—peripheral nervous system neoplasm	0.000476	0.00485	CcSEcCtD
Silodosin—Insomnia—Tretinoin—peripheral nervous system neoplasm	0.000466	0.00475	CcSEcCtD
Silodosin—Insomnia—Isotretinoin—peripheral nervous system neoplasm	0.000466	0.00475	CcSEcCtD
Silodosin—Jaundice—Etoposide—peripheral nervous system neoplasm	0.000466	0.00475	CcSEcCtD
Silodosin—Mental disorder—Vincristine—peripheral nervous system neoplasm	0.000464	0.00473	CcSEcCtD
Silodosin—Hepatobiliary disease—Etoposide—peripheral nervous system neoplasm	0.000452	0.00461	CcSEcCtD
Silodosin—Gastrointestinal disorder—Topotecan—peripheral nervous system neoplasm	0.000449	0.00457	CcSEcCtD
Silodosin—Gastrointestinal disorder—Tretinoin—peripheral nervous system neoplasm	0.000445	0.00454	CcSEcCtD
Silodosin—Gastrointestinal disorder—Isotretinoin—peripheral nervous system neoplasm	0.000445	0.00454	CcSEcCtD
Silodosin—Gastrointestinal disorder—Melphalan—peripheral nervous system neoplasm	0.000439	0.00448	CcSEcCtD
Silodosin—Cardiac disorder—Cisplatin—peripheral nervous system neoplasm	0.000435	0.00443	CcSEcCtD
Silodosin—Syncope—Alitretinoin—peripheral nervous system neoplasm	0.000429	0.00438	CcSEcCtD
Silodosin—Gastrointestinal pain—Topotecan—peripheral nervous system neoplasm	0.000425	0.00433	CcSEcCtD
Silodosin—Immune system disorder—Cisplatin—peripheral nervous system neoplasm	0.000423	0.00431	CcSEcCtD
Silodosin—Palpitations—Alitretinoin—peripheral nervous system neoplasm	0.000423	0.00431	CcSEcCtD
Silodosin—Mediastinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000422	0.0043	CcSEcCtD
Silodosin—Gastrointestinal pain—Tretinoin—peripheral nervous system neoplasm	0.000422	0.0043	CcSEcCtD
Silodosin—Gastrointestinal pain—Isotretinoin—peripheral nervous system neoplasm	0.000422	0.0043	CcSEcCtD
Silodosin—Loss of consciousness—Alitretinoin—peripheral nervous system neoplasm	0.000421	0.00429	CcSEcCtD
Silodosin—Urticaria—Topotecan—peripheral nervous system neoplasm	0.000413	0.00421	CcSEcCtD
Silodosin—Abdominal pain—Topotecan—peripheral nervous system neoplasm	0.000411	0.00419	CcSEcCtD
Silodosin—Urticaria—Tretinoin—peripheral nervous system neoplasm	0.00041	0.00417	CcSEcCtD
Silodosin—Urticaria—Isotretinoin—peripheral nervous system neoplasm	0.00041	0.00417	CcSEcCtD
Silodosin—Abdominal pain—Isotretinoin—peripheral nervous system neoplasm	0.000408	0.00415	CcSEcCtD
Silodosin—Abdominal pain—Tretinoin—peripheral nervous system neoplasm	0.000408	0.00415	CcSEcCtD
Silodosin—Unspecified disorder of skin and subcutaneous tissue—Alitretinoin—peripheral nervous system neoplasm	0.000405	0.00413	CcSEcCtD
Silodosin—Urticaria—Melphalan—peripheral nervous system neoplasm	0.000404	0.00412	CcSEcCtD
Silodosin—Dry mouth—Alitretinoin—peripheral nervous system neoplasm	0.000399	0.00406	CcSEcCtD
Silodosin—Cardiac disorder—Etoposide—peripheral nervous system neoplasm	0.000398	0.00406	CcSEcCtD
Silodosin—Hepatic function abnormal—Epirubicin—peripheral nervous system neoplasm	0.000398	0.00406	CcSEcCtD
Silodosin—Angiopathy—Etoposide—peripheral nervous system neoplasm	0.00039	0.00397	CcSEcCtD
Silodosin—Vascular purpura—Epirubicin—peripheral nervous system neoplasm	0.000389	0.00396	CcSEcCtD
Silodosin—Immune system disorder—Etoposide—peripheral nervous system neoplasm	0.000388	0.00395	CcSEcCtD
Silodosin—Mediastinal disorder—Etoposide—peripheral nervous system neoplasm	0.000387	0.00394	CcSEcCtD
Silodosin—Shock—Alitretinoin—peripheral nervous system neoplasm	0.000384	0.00392	CcSEcCtD
Silodosin—Nervous system disorder—Alitretinoin—peripheral nervous system neoplasm	0.000383	0.00391	CcSEcCtD
Silodosin—Tachycardia—Alitretinoin—peripheral nervous system neoplasm	0.000381	0.00389	CcSEcCtD
Silodosin—Skin disorder—Alitretinoin—peripheral nervous system neoplasm	0.00038	0.00387	CcSEcCtD
Silodosin—Asthenia—Topotecan—peripheral nervous system neoplasm	0.000373	0.0038	CcSEcCtD
Silodosin—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.00037	0.00377	CcSEcCtD
Silodosin—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.00037	0.00377	CcSEcCtD
Silodosin—Nervous system disorder—Vincristine—peripheral nervous system neoplasm	0.000369	0.00376	CcSEcCtD
Silodosin—Hepatic function abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000368	0.00375	CcSEcCtD
Silodosin—Pruritus—Topotecan—peripheral nervous system neoplasm	0.000368	0.00375	CcSEcCtD
Silodosin—Asthenia—Melphalan—peripheral nervous system neoplasm	0.000365	0.00372	CcSEcCtD
Silodosin—Hypotension—Alitretinoin—peripheral nervous system neoplasm	0.000365	0.00372	CcSEcCtD
Silodosin—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.000365	0.00372	CcSEcCtD
Silodosin—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.000365	0.00372	CcSEcCtD
Silodosin—Purpura—Epirubicin—peripheral nervous system neoplasm	0.000361	0.00368	CcSEcCtD
Silodosin—Pruritus—Melphalan—peripheral nervous system neoplasm	0.00036	0.00367	CcSEcCtD
Silodosin—Vascular purpura—Doxorubicin—peripheral nervous system neoplasm	0.00036	0.00367	CcSEcCtD
Silodosin—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.000356	0.00362	CcSEcCtD
Silodosin—Insomnia—Alitretinoin—peripheral nervous system neoplasm	0.000353	0.0036	CcSEcCtD
Silodosin—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000353	0.0036	CcSEcCtD
Silodosin—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.000353	0.0036	CcSEcCtD
Silodosin—Hypotension—Vincristine—peripheral nervous system neoplasm	0.000352	0.00359	CcSEcCtD
Silodosin—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.000348	0.00355	CcSEcCtD
Silodosin—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—peripheral nervous system neoplasm	0.000345	0.00352	CcSEcCtD
Silodosin—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.000345	0.00351	CcSEcCtD
Silodosin—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000344	0.0035	CcSEcCtD
Silodosin—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000341	0.00347	CcSEcCtD
Silodosin—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000341	0.00347	CcSEcCtD
Silodosin—Insomnia—Vincristine—peripheral nervous system neoplasm	0.000341	0.00347	CcSEcCtD
Silodosin—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.000337	0.00344	CcSEcCtD
Silodosin—Purpura—Doxorubicin—peripheral nervous system neoplasm	0.000334	0.0034	CcSEcCtD
Silodosin—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.000333	0.0034	CcSEcCtD
Silodosin—Loss of consciousness—Etoposide—peripheral nervous system neoplasm	0.000328	0.00335	CcSEcCtD
Silodosin—Rash—Topotecan—peripheral nervous system neoplasm	0.000328	0.00334	CcSEcCtD
Silodosin—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000327	0.00334	CcSEcCtD
Silodosin—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.000327	0.00333	CcSEcCtD
Silodosin—Headache—Topotecan—peripheral nervous system neoplasm	0.000326	0.00332	CcSEcCtD
Silodosin—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000325	0.00331	CcSEcCtD
Silodosin—Rash—Tretinoin—peripheral nervous system neoplasm	0.000325	0.00331	CcSEcCtD
Silodosin—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000325	0.00331	CcSEcCtD
Silodosin—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.000325	0.00331	CcSEcCtD
Silodosin—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000325	0.00331	CcSEcCtD
Silodosin—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000325	0.00331	CcSEcCtD
Silodosin—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000323	0.0033	CcSEcCtD
Silodosin—Headache—Tretinoin—peripheral nervous system neoplasm	0.000323	0.00329	CcSEcCtD
Silodosin—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000323	0.00329	CcSEcCtD
Silodosin—Liver function test abnormal—Epirubicin—peripheral nervous system neoplasm	0.000321	0.00327	CcSEcCtD
Silodosin—Rash—Melphalan—peripheral nervous system neoplasm	0.000321	0.00327	CcSEcCtD
Silodosin—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000321	0.00327	CcSEcCtD
Silodosin—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.00032	0.00326	CcSEcCtD
Silodosin—Orthostatic hypotension—Epirubicin—peripheral nervous system neoplasm	0.000318	0.00324	CcSEcCtD
Silodosin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000316	0.00322	CcSEcCtD
Silodosin—Breast disorder—Epirubicin—peripheral nervous system neoplasm	0.000314	0.0032	CcSEcCtD
Silodosin—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.000311	0.00317	CcSEcCtD
Silodosin—Nasopharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000311	0.00317	CcSEcCtD
Silodosin—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.00031	0.00316	CcSEcCtD
Silodosin—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000309	0.00315	CcSEcCtD
Silodosin—Nausea—Topotecan—peripheral nervous system neoplasm	0.000309	0.00315	CcSEcCtD
Silodosin—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000308	0.00314	CcSEcCtD
Silodosin—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000306	0.00312	CcSEcCtD
Silodosin—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000306	0.00312	CcSEcCtD
Silodosin—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000302	0.00308	CcSEcCtD
Silodosin—Nausea—Melphalan—peripheral nervous system neoplasm	0.000302	0.00308	CcSEcCtD
Silodosin—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000298	0.00303	CcSEcCtD
Silodosin—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000298	0.00303	CcSEcCtD
Silodosin—Liver function test abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000297	0.00303	CcSEcCtD
Silodosin—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000296	0.00302	CcSEcCtD
Silodosin—Orthostatic hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000294	0.003	CcSEcCtD
Silodosin—Breast disorder—Doxorubicin—peripheral nervous system neoplasm	0.000291	0.00296	CcSEcCtD
Silodosin—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000288	0.00294	CcSEcCtD
Silodosin—Nasopharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000288	0.00293	CcSEcCtD
Silodosin—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000287	0.00293	CcSEcCtD
Silodosin—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000285	0.0029	CcSEcCtD
Silodosin—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.00028	0.00286	CcSEcCtD
Silodosin—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000276	0.00282	CcSEcCtD
Silodosin—Asthenia—Vincristine—peripheral nervous system neoplasm	0.00027	0.00275	CcSEcCtD
Silodosin—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000267	0.00272	CcSEcCtD
Silodosin—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000266	0.00271	CcSEcCtD
Silodosin—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000263	0.00268	CcSEcCtD
Silodosin—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.000261	0.00266	CcSEcCtD
Silodosin—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000258	0.00263	CcSEcCtD
Silodosin—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000258	0.00263	CcSEcCtD
Silodosin—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	0.000254	0.00258	CcSEcCtD
Silodosin—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.000252	0.00256	CcSEcCtD
Silodosin—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.00025	0.00255	CcSEcCtD
Silodosin—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000249	0.00254	CcSEcCtD
Silodosin—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000249	0.00254	CcSEcCtD
Silodosin—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000246	0.00251	CcSEcCtD
Silodosin—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000246	0.00251	CcSEcCtD
Silodosin—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000245	0.00249	CcSEcCtD
Silodosin—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000242	0.00247	CcSEcCtD
Silodosin—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.000242	0.00246	CcSEcCtD
Silodosin—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000241	0.00246	CcSEcCtD
Silodosin—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000239	0.00243	CcSEcCtD
Silodosin—Rash—Vincristine—peripheral nervous system neoplasm	0.000237	0.00242	CcSEcCtD
Silodosin—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000237	0.00242	CcSEcCtD
Silodosin—Headache—Vincristine—peripheral nervous system neoplasm	0.000236	0.0024	CcSEcCtD
Silodosin—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	0.000235	0.00239	CcSEcCtD
Silodosin—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	0.000233	0.00237	CcSEcCtD
Silodosin—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000232	0.00237	CcSEcCtD
Silodosin—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000228	0.00232	CcSEcCtD
Silodosin—Nausea—Vincristine—peripheral nervous system neoplasm	0.000224	0.00228	CcSEcCtD
Silodosin—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.000223	0.00228	CcSEcCtD
Silodosin—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000219	0.00223	CcSEcCtD
Silodosin—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.000218	0.00223	CcSEcCtD
Silodosin—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000217	0.00222	CcSEcCtD
Silodosin—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000217	0.00221	CcSEcCtD
Silodosin—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000216	0.0022	CcSEcCtD
Silodosin—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000211	0.00215	CcSEcCtD
Silodosin—Rash—Cisplatin—peripheral nervous system neoplasm	0.00021	0.00214	CcSEcCtD
Silodosin—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.00021	0.00214	CcSEcCtD
Silodosin—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000209	0.00213	CcSEcCtD
Silodosin—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.000207	0.00211	CcSEcCtD
Silodosin—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.000202	0.00206	CcSEcCtD
Silodosin—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000202	0.00206	CcSEcCtD
Silodosin—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000201	0.00205	CcSEcCtD
Silodosin—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000201	0.00205	CcSEcCtD
Silodosin—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000198	0.00202	CcSEcCtD
Silodosin—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000195	0.00199	CcSEcCtD
Silodosin—Rash—Etoposide—peripheral nervous system neoplasm	0.000192	0.00196	CcSEcCtD
Silodosin—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000192	0.00196	CcSEcCtD
Silodosin—Headache—Etoposide—peripheral nervous system neoplasm	0.000191	0.00195	CcSEcCtD
Silodosin—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000188	0.00191	CcSEcCtD
Silodosin—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000185	0.00189	CcSEcCtD
Silodosin—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000184	0.00188	CcSEcCtD
Silodosin—Nausea—Etoposide—peripheral nervous system neoplasm	0.000181	0.00185	CcSEcCtD
Silodosin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000177	0.00181	CcSEcCtD
Silodosin—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000174	0.00178	CcSEcCtD
Silodosin—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000174	0.00177	CcSEcCtD
Silodosin—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000171	0.00175	CcSEcCtD
Silodosin—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.00017	0.00174	CcSEcCtD
Silodosin—Shock—Epirubicin—peripheral nervous system neoplasm	0.000168	0.00171	CcSEcCtD
Silodosin—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000168	0.00171	CcSEcCtD
Silodosin—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000167	0.0017	CcSEcCtD
Silodosin—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000166	0.00169	CcSEcCtD
Silodosin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000164	0.00167	CcSEcCtD
Silodosin—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000161	0.00164	CcSEcCtD
Silodosin—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.00016	0.00163	CcSEcCtD
Silodosin—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000156	0.00159	CcSEcCtD
Silodosin—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000155	0.00158	CcSEcCtD
Silodosin—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000155	0.00158	CcSEcCtD
Silodosin—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000154	0.00157	CcSEcCtD
Silodosin—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000154	0.00157	CcSEcCtD
Silodosin—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000148	0.00151	CcSEcCtD
Silodosin—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000148	0.0015	CcSEcCtD
Silodosin—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000143	0.00146	CcSEcCtD
Silodosin—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.00014	0.00142	CcSEcCtD
Silodosin—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000137	0.00139	CcSEcCtD
Silodosin—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000136	0.00138	CcSEcCtD
Silodosin—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000135	0.00138	CcSEcCtD
Silodosin—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000129	0.00132	CcSEcCtD
Silodosin—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000126	0.00128	CcSEcCtD
Silodosin—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000125	0.00127	CcSEcCtD
Silodosin—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000123	0.00125	CcSEcCtD
Silodosin—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000121	0.00123	CcSEcCtD
Silodosin—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000117	0.00119	CcSEcCtD
Silodosin—UGT2B7—Codeine and Morphine Metabolism—ABCB1—peripheral nervous system neoplasm	0.000116	0.0841	CbGpPWpGaD
Silodosin—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000114	0.00116	CcSEcCtD
Silodosin—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000113	0.00115	CcSEcCtD
Silodosin—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000112	0.00114	CcSEcCtD
Silodosin—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000108	0.0011	CcSEcCtD
Silodosin—Rash—Epirubicin—peripheral nervous system neoplasm	0.000108	0.0011	CcSEcCtD
Silodosin—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000108	0.0011	CcSEcCtD
Silodosin—ADRA1D—GPCRs, Other—ADGRV1—peripheral nervous system neoplasm	0.000107	0.078	CbGpPWpGaD
Silodosin—Headache—Epirubicin—peripheral nervous system neoplasm	0.000107	0.00109	CcSEcCtD
Silodosin—ABCB4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	0.000105	0.0766	CbGpPWpGaD
Silodosin—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000105	0.00107	CcSEcCtD
Silodosin—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000102	0.00104	CcSEcCtD
Silodosin—Rash—Doxorubicin—peripheral nervous system neoplasm	9.98e-05	0.00102	CcSEcCtD
Silodosin—ABCB4—Fatty acid, triacylglycerol, and ketone body metabolism—HSD17B12—peripheral nervous system neoplasm	9.97e-05	0.0724	CbGpPWpGaD
Silodosin—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	9.97e-05	0.00102	CcSEcCtD
Silodosin—Headache—Doxorubicin—peripheral nervous system neoplasm	9.91e-05	0.00101	CcSEcCtD
Silodosin—Nausea—Doxorubicin—peripheral nervous system neoplasm	9.4e-05	0.000958	CcSEcCtD
Silodosin—ADRA1A—Endothelin Pathways—COX2—peripheral nervous system neoplasm	5.18e-05	0.0376	CbGpPWpGaD
Silodosin—ABCB4—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	3.97e-05	0.0288	CbGpPWpGaD
Silodosin—CYP3A4—Codeine and Morphine Metabolism—ABCB1—peripheral nervous system neoplasm	2.66e-05	0.0193	CbGpPWpGaD
Silodosin—ABCB4—Metabolism—PPIP5K2—peripheral nervous system neoplasm	2.62e-05	0.019	CbGpPWpGaD
Silodosin—CYP3A4—Irinotecan Pathway—BCHE—peripheral nervous system neoplasm	2.26e-05	0.0164	CbGpPWpGaD
Silodosin—ADRA1A—Endothelin Pathways—GNAS—peripheral nervous system neoplasm	2.2e-05	0.016	CbGpPWpGaD
Silodosin—ADRA1D—G alpha (q) signalling events—NTS—peripheral nervous system neoplasm	1.9e-05	0.0138	CbGpPWpGaD
Silodosin—ABCB4—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.77e-05	0.0128	CbGpPWpGaD
Silodosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—NTS—peripheral nervous system neoplasm	1.7e-05	0.0123	CbGpPWpGaD
Silodosin—ADRA1B—G alpha (q) signalling events—NTS—peripheral nervous system neoplasm	1.58e-05	0.0115	CbGpPWpGaD
Silodosin—ABCB4—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.47e-05	0.0107	CbGpPWpGaD
Silodosin—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—peripheral nervous system neoplasm	1.46e-05	0.0106	CbGpPWpGaD
Silodosin—UGT2B7—NRF2 pathway—SLC2A1—peripheral nervous system neoplasm	1.44e-05	0.0104	CbGpPWpGaD
Silodosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—NTS—peripheral nervous system neoplasm	1.41e-05	0.0102	CbGpPWpGaD
Silodosin—ADRA1A—G alpha (q) signalling events—NTS—peripheral nervous system neoplasm	1.4e-05	0.0102	CbGpPWpGaD
Silodosin—ABCB4—Metabolism—GNS—peripheral nervous system neoplasm	1.28e-05	0.00929	CbGpPWpGaD
Silodosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—NTS—peripheral nervous system neoplasm	1.26e-05	0.00914	CbGpPWpGaD
Silodosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—NTS—peripheral nervous system neoplasm	1.25e-05	0.0091	CbGpPWpGaD
Silodosin—ABCB4—Metabolism—NME1—peripheral nervous system neoplasm	1.23e-05	0.00891	CbGpPWpGaD
Silodosin—ABCB4—Metabolism—COX2—peripheral nervous system neoplasm	1.18e-05	0.00857	CbGpPWpGaD
Silodosin—UGT2B7—NRF2 pathway—HGF—peripheral nervous system neoplasm	1.1e-05	0.008	CbGpPWpGaD
Silodosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—NTS—peripheral nervous system neoplasm	1.04e-05	0.00759	CbGpPWpGaD
Silodosin—ABCB1—HIF-1-alpha transcription factor network—SLC2A1—peripheral nervous system neoplasm	1.01e-05	0.00734	CbGpPWpGaD
Silodosin—ADRA1D—GPCR ligand binding—NTS—peripheral nervous system neoplasm	9.58e-06	0.00696	CbGpPWpGaD
Silodosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—NTS—peripheral nervous system neoplasm	9.28e-06	0.00674	CbGpPWpGaD
Silodosin—ADRA1D—GPCR ligand binding—CD55—peripheral nervous system neoplasm	9.19e-06	0.00667	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—PPIP5K2—peripheral nervous system neoplasm	9.04e-06	0.00657	CbGpPWpGaD
Silodosin—ADRA1D—Calcium Regulation in the Cardiac Cell—GNAS—peripheral nervous system neoplasm	8.95e-06	0.0065	CbGpPWpGaD
Silodosin—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	8.78e-06	0.00637	CbGpPWpGaD
Silodosin—ADRA1D—G alpha (q) signalling events—KNG1—peripheral nervous system neoplasm	8.54e-06	0.0062	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—NME1—peripheral nervous system neoplasm	8.48e-06	0.00616	CbGpPWpGaD
Silodosin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	8.36e-06	0.00607	CbGpPWpGaD
Silodosin—ADRA1B—GPCR ligand binding—NTS—peripheral nervous system neoplasm	7.95e-06	0.00578	CbGpPWpGaD
Silodosin—ABCB4—Metabolism—ENO2—peripheral nervous system neoplasm	7.75e-06	0.00563	CbGpPWpGaD
Silodosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—KNG1—peripheral nervous system neoplasm	7.63e-06	0.00555	CbGpPWpGaD
Silodosin—ADRA1B—GPCR ligand binding—CD55—peripheral nervous system neoplasm	7.62e-06	0.00554	CbGpPWpGaD
Silodosin—ADRA1B—Calcium Regulation in the Cardiac Cell—GNAS—peripheral nervous system neoplasm	7.43e-06	0.0054	CbGpPWpGaD
Silodosin—ADRA1B—LPA receptor mediated events—CASP3—peripheral nervous system neoplasm	7.28e-06	0.00529	CbGpPWpGaD
Silodosin—ADRA1B—G alpha (q) signalling events—KNG1—peripheral nervous system neoplasm	7.08e-06	0.00515	CbGpPWpGaD
Silodosin—ADRA1A—GPCR ligand binding—NTS—peripheral nervous system neoplasm	7.06e-06	0.00513	CbGpPWpGaD
Silodosin—ADRA1A—GPCR ligand binding—CD55—peripheral nervous system neoplasm	6.77e-06	0.00492	CbGpPWpGaD
Silodosin—ADRA1A—Calcium Regulation in the Cardiac Cell—GNAS—peripheral nervous system neoplasm	6.6e-06	0.00479	CbGpPWpGaD
Silodosin—ABCB4—Metabolism—BCHE—peripheral nervous system neoplasm	6.55e-06	0.00475	CbGpPWpGaD
Silodosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—KNG1—peripheral nervous system neoplasm	6.34e-06	0.0046	CbGpPWpGaD
Silodosin—ADRA1A—G alpha (q) signalling events—KNG1—peripheral nervous system neoplasm	6.29e-06	0.00457	CbGpPWpGaD
Silodosin—ABCB4—Metabolism—SLC2A1—peripheral nervous system neoplasm	6.24e-06	0.00454	CbGpPWpGaD
Silodosin—ABCB4—Metabolism—TH—peripheral nervous system neoplasm	6.15e-06	0.00447	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—HSD17B12—peripheral nervous system neoplasm	6.1e-06	0.00443	CbGpPWpGaD
Silodosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	5.65e-06	0.00411	CbGpPWpGaD
Silodosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—KNG1—peripheral nervous system neoplasm	5.63e-06	0.00409	CbGpPWpGaD
Silodosin—ADRA1D—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	5.41e-06	0.00393	CbGpPWpGaD
Silodosin—ABCB4—Metabolism—GNAS—peripheral nervous system neoplasm	5.02e-06	0.00365	CbGpPWpGaD
Silodosin—ABCB4—Metabolism—ABCB1—peripheral nervous system neoplasm	4.93e-06	0.00358	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—NTS—peripheral nervous system neoplasm	4.92e-06	0.00357	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—CD55—peripheral nervous system neoplasm	4.71e-06	0.00342	CbGpPWpGaD
Silodosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	4.69e-06	0.00341	CbGpPWpGaD
Silodosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—PTPN11—peripheral nervous system neoplasm	4.64e-06	0.00337	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	4.49e-06	0.00326	CbGpPWpGaD
Silodosin—ADRA1B—LPA receptor mediated events—HRAS—peripheral nervous system neoplasm	4.47e-06	0.00324	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—GNS—peripheral nervous system neoplasm	4.41e-06	0.00321	CbGpPWpGaD
Silodosin—ADRA1B—AMPK Signaling—TP53—peripheral nervous system neoplasm	4.4e-06	0.00319	CbGpPWpGaD
Silodosin—ADRA1D—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	4.31e-06	0.00313	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—NME1—peripheral nervous system neoplasm	4.23e-06	0.00307	CbGpPWpGaD
Silodosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	4.17e-06	0.00303	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	4.16e-06	0.00302	CbGpPWpGaD
Silodosin—ADRA1D—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	4.1e-06	0.00298	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—NTS—peripheral nervous system neoplasm	4.08e-06	0.00296	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—COX2—peripheral nervous system neoplasm	4.07e-06	0.00296	CbGpPWpGaD
Silodosin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—peripheral nervous system neoplasm	4.02e-06	0.00292	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	3.99e-06	0.0029	CbGpPWpGaD
Silodosin—ADRA1B—LPA receptor mediated events—AKT1—peripheral nervous system neoplasm	3.94e-06	0.00286	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—CD55—peripheral nervous system neoplasm	3.91e-06	0.00284	CbGpPWpGaD
Silodosin—ADRA1A—AMPK Signaling—TP53—peripheral nervous system neoplasm	3.91e-06	0.00284	CbGpPWpGaD
Silodosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—PTPN11—peripheral nervous system neoplasm	3.85e-06	0.0028	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	3.79e-06	0.00275	CbGpPWpGaD
Silodosin—ADRA1D—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	3.76e-06	0.00273	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—VIP—peripheral nervous system neoplasm	3.73e-06	0.00271	CbGpPWpGaD
Silodosin—ADRA1B—AMPK Signaling—AKT1—peripheral nervous system neoplasm	3.71e-06	0.0027	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—NTS—peripheral nervous system neoplasm	3.62e-06	0.00263	CbGpPWpGaD
Silodosin—ADRA1B—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	3.57e-06	0.0026	CbGpPWpGaD
Silodosin—ABCB1—Allograft Rejection—CASP3—peripheral nervous system neoplasm	3.51e-06	0.00255	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—CD55—peripheral nervous system neoplasm	3.48e-06	0.00252	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	3.47e-06	0.00252	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	3.44e-06	0.0025	CbGpPWpGaD
Silodosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—PTPN11—peripheral nervous system neoplasm	3.42e-06	0.00248	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	3.41e-06	0.00247	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	3.37e-06	0.00245	CbGpPWpGaD
Silodosin—ADRA1A—AMPK Signaling—AKT1—peripheral nervous system neoplasm	3.3e-06	0.0024	CbGpPWpGaD
Silodosin—ABCB1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	3.24e-06	0.00235	CbGpPWpGaD
Silodosin—ADRA1A—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	3.17e-06	0.00231	CbGpPWpGaD
Silodosin—ADRA1B—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	3.12e-06	0.00227	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—VIP—peripheral nervous system neoplasm	3.09e-06	0.00225	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	3.03e-06	0.0022	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—NTS—peripheral nervous system neoplasm	2.9e-06	0.00211	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	2.85e-06	0.00207	CbGpPWpGaD
Silodosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—peripheral nervous system neoplasm	2.79e-06	0.00203	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—CD55—peripheral nervous system neoplasm	2.78e-06	0.00202	CbGpPWpGaD
Silodosin—ADRA1A—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	2.78e-06	0.00202	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—VIP—peripheral nervous system neoplasm	2.75e-06	0.002	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—ENO2—peripheral nervous system neoplasm	2.67e-06	0.00194	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	2.54e-06	0.00184	CbGpPWpGaD
Silodosin—ADRA1D—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	2.43e-06	0.00177	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—NTS—peripheral nervous system neoplasm	2.41e-06	0.00175	CbGpPWpGaD
Silodosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—peripheral nervous system neoplasm	2.32e-06	0.00168	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—CD55—peripheral nervous system neoplasm	2.31e-06	0.00168	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.28e-06	0.00165	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—BCHE—peripheral nervous system neoplasm	2.26e-06	0.00164	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	2.21e-06	0.0016	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—VIP—peripheral nervous system neoplasm	2.2e-06	0.0016	CbGpPWpGaD
Silodosin—ABCB1—HIF-1-alpha transcription factor network—AKT1—peripheral nervous system neoplasm	2.2e-06	0.00159	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.16e-06	0.00157	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—NTS—peripheral nervous system neoplasm	2.14e-06	0.00156	CbGpPWpGaD
Silodosin—ADRA1D—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	2.13e-06	0.00155	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—TH—peripheral nervous system neoplasm	2.12e-06	0.00154	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—PPIP5K2—peripheral nervous system neoplasm	2.08e-06	0.00151	CbGpPWpGaD
Silodosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—peripheral nervous system neoplasm	2.06e-06	0.00149	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—CD55—peripheral nervous system neoplasm	2.05e-06	0.00149	CbGpPWpGaD
Silodosin—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	2.04e-06	0.00148	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	2.03e-06	0.00148	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	2.02e-06	0.00147	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	1.93e-06	0.0014	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	1.91e-06	0.00139	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	1.83e-06	0.00133	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—VIP—peripheral nervous system neoplasm	1.83e-06	0.00133	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	1.79e-06	0.0013	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	1.77e-06	0.00128	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—GNAS—peripheral nervous system neoplasm	1.73e-06	0.00126	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	1.73e-06	0.00126	CbGpPWpGaD
Silodosin—ABCB1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	1.72e-06	0.00125	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—ABCB1—peripheral nervous system neoplasm	1.7e-06	0.00124	CbGpPWpGaD
Silodosin—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	1.69e-06	0.00123	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	1.69e-06	0.00122	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—GNS—peripheral nervous system neoplasm	1.65e-06	0.0012	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	1.63e-06	0.00118	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—VIP—peripheral nervous system neoplasm	1.62e-06	0.00118	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	1.6e-06	0.00116	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—NME1—peripheral nervous system neoplasm	1.58e-06	0.00115	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	1.57e-06	0.00114	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	1.53e-06	0.00111	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—COX2—peripheral nervous system neoplasm	1.52e-06	0.0011	CbGpPWpGaD
Silodosin—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	1.5e-06	0.00109	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	1.5e-06	0.00109	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	1.42e-06	0.00103	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.4e-06	0.00102	CbGpPWpGaD
Silodosin—ABCB1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.38e-06	0.001	CbGpPWpGaD
Silodosin—ABCB4—Metabolism—AKT1—peripheral nervous system neoplasm	1.36e-06	0.000985	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	1.35e-06	0.000983	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.34e-06	0.000975	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.31e-06	0.000948	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	1.27e-06	0.00092	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.24e-06	0.000903	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.14e-06	0.000829	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	1.12e-06	0.000817	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.11e-06	0.000809	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	1.11e-06	0.000807	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.08e-06	0.000787	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.03e-06	0.00075	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—GNS—peripheral nervous system neoplasm	1.01e-06	0.000736	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—ENO2—peripheral nervous system neoplasm	9.97e-07	0.000724	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	9.9e-07	0.000719	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—NME1—peripheral nervous system neoplasm	9.72e-07	0.000706	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	9.62e-07	0.000699	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—GNAS—peripheral nervous system neoplasm	9.47e-07	0.000688	CbGpPWpGaD
Silodosin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	9.38e-07	0.000682	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—COX2—peripheral nervous system neoplasm	9.36e-07	0.00068	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	9.17e-07	0.000666	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—BCHE—peripheral nervous system neoplasm	8.42e-07	0.000612	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	8.41e-07	0.000611	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	8.07e-07	0.000586	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—SLC2A1—peripheral nervous system neoplasm	8.04e-07	0.000584	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	7.93e-07	0.000576	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—TH—peripheral nervous system neoplasm	7.92e-07	0.000575	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	6.7e-07	0.000487	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	6.58e-07	0.000478	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—GNAS—peripheral nervous system neoplasm	6.46e-07	0.00047	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	6.27e-07	0.000455	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	6.14e-07	0.000446	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	5.95e-07	0.000432	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	5.91e-07	0.000429	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	5.85e-07	0.000425	CbGpPWpGaD
Silodosin—ADRA1D—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	5.74e-07	0.000417	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—CASP3—peripheral nervous system neoplasm	5.69e-07	0.000413	CbGpPWpGaD
Silodosin—ADRA1D—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	5.21e-07	0.000379	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	5.2e-07	0.000378	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	5.19e-07	0.000377	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	4.95e-07	0.00036	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	4.9e-07	0.000356	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	4.88e-07	0.000354	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—NRAS—peripheral nervous system neoplasm	4.77e-07	0.000346	CbGpPWpGaD
Silodosin—ADRA1B—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	4.77e-07	0.000346	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—CASP3—peripheral nervous system neoplasm	4.72e-07	0.000343	CbGpPWpGaD
Silodosin—UGT2B7—Metabolism—AKT1—peripheral nervous system neoplasm	4.68e-07	0.00034	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	4.62e-07	0.000336	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—MYC—peripheral nervous system neoplasm	4.44e-07	0.000323	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	4.35e-07	0.000316	CbGpPWpGaD
Silodosin—ADRA1B—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	4.33e-07	0.000314	CbGpPWpGaD
Silodosin—ADRA1A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	4.23e-07	0.000308	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	4.19e-07	0.000305	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	3.98e-07	0.000289	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—NRAS—peripheral nervous system neoplasm	3.96e-07	0.000288	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	3.91e-07	0.000284	CbGpPWpGaD
Silodosin—ADRA1A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	3.84e-07	0.000279	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—MYC—peripheral nervous system neoplasm	3.69e-07	0.000268	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.65e-07	0.000265	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	3.52e-07	0.000255	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.49e-07	0.000253	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—MYC—peripheral nervous system neoplasm	3.27e-07	0.000238	CbGpPWpGaD
Silodosin—ADRA1D—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.08e-07	0.000224	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.03e-07	0.00022	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—HRAS—peripheral nervous system neoplasm	2.9e-07	0.00021	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—TP53—peripheral nervous system neoplasm	2.69e-07	0.000195	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	2.57e-07	0.000187	CbGpPWpGaD
Silodosin—ADRA1B—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.56e-07	0.000186	CbGpPWpGaD
Silodosin—ADRA1A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.27e-07	0.000165	CbGpPWpGaD
Silodosin—ABCB1—Metabolism—AKT1—peripheral nervous system neoplasm	1.74e-07	0.000127	CbGpPWpGaD
Silodosin—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	1.08e-07	7.81e-05	CbGpPWpGaD
